On the issue of transparency and reproducibility in nanomedicine.
作者信息
Leong Hon S, Butler Kimberly S, Brinker C Jeffrey, Azzawi May, Conlan Steve, Dufés Christine, Owen Andrew, Rannard Steve, Scott Chris, Chen Chunying, Dobrovolskaia Marina A, Kozlov Serguei V, Prina-Mello Adriele, Schmid Ruth, Wick Peter, Caputo Fanny, Boisseau Patrick, Crist Rachael M, McNeil Scott E, Fadeel Bengt, Tran Lang, Hansen Steffen Foss, Hartmann Nanna B, Clausen Lauge P W, Skjolding Lars M, Baun Anders, Ågerstrand Marlene, Gu Zhen, Lamprou Dimitrios A, Hoskins Clare, Huang Leaf, Song Wantong, Cao Huiliang, Liu Xuanyong, Jandt Klaus D, Jiang Wen, Kim Betty Y S, Wheeler Korin E, Chetwynd Andrew J, Lynch Iseult, Moghimi Seyed Moein, Nel André, Xia Tian, Weiss Paul S, Sarmento Bruno, das Neves José, Santos Hélder A, Santos Luis, Mitragotri Samir, Little Steve, Peer Dan, Amiji Mansoor M, Alonso Maria José, Petri-Fink Alke, Balog Sandor, Lee Aaron, Drasler Barbara, Rothen-Rutishauser Barbara, Wilhelm Stefan, Acar Handan, Harrison Roger G, Mao Chuanbin, Mukherjee Priyabrata, Ramesh Rajagopal, McNally Lacey R, Busatto Sara, Wolfram Joy, Bergese Paolo, Ferrari Mauro, Fang Ronnie H, Zhang Liangfang, Zheng Jie, Peng Chuanqi, Du Bujie, Yu Mengxiao, Charron Danielle M, Zheng Gang, Pastore Chiara
机构信息
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
出版信息
Nat Nanotechnol. 2019 Jul;14(7):629-635. doi: 10.1038/s41565-019-0496-9.
Abstract
摘要
相似文献
1
On the issue of transparency and reproducibility in nanomedicine.关于纳米医学中的透明度和可重复性问题。
Nat Nanotechnol. 2019 Jul;14(7):629-635. doi: 10.1038/s41565-019-0496-9.
2
[Vancouver Style or NLM Format: Towards citation standardization].[温哥华格式或NLM格式：迈向引用标准化]
Rev Med Inst Mex Seguro Soc. 2025 Jul 1;63(4):e6384. doi: 10.5281/zenodo.15644343.
3
Defining the Boundaries of AI Use in Scientific Writing: A Comparative Review of Editorial Policies.界定科学写作中人工智能使用的界限：编辑政策的比较综述
J Korean Med Sci. 2025 Jun 16;40(23):e187. doi: 10.3346/jkms.2025.40.e187.
4
Technical editing of research reports in biomedical journals.生物医学期刊研究报告的技术编辑。
Cochrane Database Syst Rev. 2008 Oct 8;2008(4):MR000002. doi: 10.1002/14651858.MR000002.pub3.
5
Technical editing of research reports in biomedical journals.生物医学期刊研究报告的技术编辑
Cochrane Database Syst Rev. 2007 Apr 18(2):MR000002. doi: 10.1002/14651858.MR000002.pub2.
6
Advances in Nanomedicine for Cancer Theranostics.癌症诊疗纳米医学的进展
Biomed Mater. 2025 Jun 18;20(4). doi: 10.1088/1748-605X/addf26.
7
In-house editorials and journalistic pieces comprise a massive corpus in the scientific literature that can be improved.内部社论和新闻报道文章构成了科学文献中一个庞大且有待改进的语料库。
Eur J Clin Invest. 2025 Aug;55(8):e70061. doi: 10.1111/eci.70061. Epub 2025 May 9.
8
Challenges in the implementation of MIRIBEL criteria on nanobiomed manuscripts.在纳米生物医学稿件中实施MIRIBEL标准所面临的挑战。
Nat Nanotechnol. 2019 Jul;14(7):627-628. doi: 10.1038/s41565-019-0498-7.
9
Setting standards to promote progress in bio-nano science.制定标准以促进生物纳米科学的进步。
Nat Nanotechnol. 2019 Jul;14(7):626. doi: 10.1038/s41565-019-0497-8.
10
Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.临床指南和支付方政策对慢性下腰痛融合治疗的影响。
Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S144-63. doi: 10.1097/BRS.0b013e31822ef5b4.
引用本文的文献
1
Nanotechnology for immuno-oncology.免疫肿瘤学的纳米技术
Nat Cancer. 2025 Aug 7. doi: 10.1038/s43018-025-01025-x.
2
Mass spectrometry-based top-down proteomics for proteoform profiling of protein coronas.基于质谱的自上而下蛋白质组学用于蛋白质冠层的蛋白质异构体分析。
Nat Protoc. 2025 Aug 5. doi: 10.1038/s41596-025-01229-6.
3
Systemic IFN-I Synergizes with Topical TLR7/8 Agonists to Suppress Metastatic Tumors.全身性I型干扰素与局部TLR7/8激动剂协同作用以抑制转移性肿瘤。
Research (Wash D C). 2025 Jun 21;8:0739. doi: 10.34133/research.0739. eCollection 2025.
4
Nanoparticles and Nanomaterials: A Review from the Standpoint of Pharmacy and Medicine.纳米颗粒与纳米材料：从药学与医学角度的综述
Pharmaceutics. 2025 May 16;17(5):655. doi: 10.3390/pharmaceutics17050655.
5
Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy.利用纳米载体的力量开发肿瘤微环境以增强癌症治疗效果
Pharmaceuticals (Basel). 2025 May 19;18(5):746. doi: 10.3390/ph18050746.
6
Development of manganese ferrite coated with Prussian blue as an efficient contrast agent for applications in magnetic resonance imaging.普鲁士蓝包覆的锰铁氧体作为磁共振成像应用中一种高效造影剂的研发。
Sci Rep. 2025 Apr 23;15(1):14150. doi: 10.1038/s41598-025-98348-7.
7
The Contribution of Nanomedicine in Ocular Oncology.纳米医学在眼部肿瘤学中的贡献。
Cancers (Basel). 2025 Mar 31;17(7):1186. doi: 10.3390/cancers17071186.
8
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications.用于临床应用中CRISPR-Cas9递送的精准靶向纳米颗粒
Nanomaterials (Basel). 2025 Apr 2;15(7):540. doi: 10.3390/nano15070540.
9
Genetic modulation of rare earth nanoparticle biotransformation shapes biological outcomes.稀土纳米颗粒生物转化的基因调控塑造生物学结果。
Nat Commun. 2025 Apr 11;16(1):3429. doi: 10.1038/s41467-025-58520-z.
10
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group.用于基因编辑的先进递送系统：来自GenE-HumDi成本行动工作组的全面综述
Mol Ther Nucleic Acids. 2025 Jan 17;36(1):102457. doi: 10.1016/j.omtn.2025.102457. eCollection 2025 Mar 11.
本文引用的文献
1
Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity.测量纳米药物的粒径分布，EUNCL 和 NCI-NCL 的联合观点。一种结合正交测量和逐步增加复杂性的方法。
J Control Release. 2019 Apr 10;299:31-43. doi: 10.1016/j.jconrel.2019.02.030. Epub 2019 Feb 21.
2
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.细胞外囊泡研究的最低限度信息2018（MISEV2018）：国际细胞外囊泡协会的立场声明及MISEV2014指南的更新
J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.
3
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics.利用基于成像的药代动力学研究介孔硅纳米颗粒性质对体内处置的影响。
Nat Commun. 2018 Oct 31;9(1):4551. doi: 10.1038/s41467-018-06730-z.
4
Minimum information reporting in bio-nano experimental literature.生物纳米实验文献的最低信息报告。
Nat Nanotechnol. 2018 Sep;13(9):777-785. doi: 10.1038/s41565-018-0246-4. Epub 2018 Sep 6.
5
Reopening the dialogue.重新开启对话。
Nat Nanotechnol. 2018 Sep;13(9):765. doi: 10.1038/s41565-018-0262-4.
6
Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model.氧化石墨烯的表面氧化决定了其在肺部毒性模型中对巨噬细胞的膜损伤、脂质过氧化和细胞毒性。
ACS Nano. 2018 Feb 27;12(2):1390-1402. doi: 10.1021/acsnano.7b07737. Epub 2018 Jan 22.
7
Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.设计用于临床前肿瘤生长抑制的纳米药物体内疗效研究。
Methods Mol Biol. 2018;1682:241-253. doi: 10.1007/978-1-4939-7352-1_20.
8
Evaluating Nanomedicines: Obstacles and Advancements.评估纳米药物：障碍与进展
Methods Mol Biol. 2018;1682:3-16. doi: 10.1007/978-1-4939-7352-1_1.
9
Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer.肿瘤穿透肽增强基于硅质体的化疗药物对胰腺癌的转胞吞作用。
J Clin Invest. 2017 May 1;127(5):2007-2018. doi: 10.1172/JCI92284. Epub 2017 Apr 17.
10
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.EV-TRACK：在细胞外囊泡研究中透明报告和集中知识。
Nat Methods. 2017 Feb 28;14(3):228-232. doi: 10.1038/nmeth.4185.
Zotero 插件